These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 34369561)

  • 1. CDX2 inducible microRNAs sustain colon cancer by targeting multiple DNA damage response pathway factors.
    Priya S; Kaur E; Kulshrestha S; Pandit A; Gross I; Kumar N; Agarwal H; Khan A; Shyam R; Bhagat P; Prabhu JS; Nagarajan P; Deo SVS; Bajaj A; Freund JN; Mukhopadhyay A; Sengupta S
    J Cell Sci; 2021 Aug; 134(15):. PubMed ID: 34369561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer-associated fibroblast-derived exosomal microRNA-24-3p enhances colon cancer cell resistance to MTX by down-regulating CDX2/HEPH axis.
    Zhang HW; Shi Y; Liu JB; Wang HM; Wang PY; Wu ZJ; Li L; Gu LP; Cao PS; Wang GR; Ma YS; Fu D
    J Cell Mol Med; 2021 Apr; 25(8):3699-3713. PubMed ID: 33621425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-214-mediated downregulation of RNF8 induces chromosomal instability in ovarian cancer cells.
    Wang Z; Yin H; Zhang Y; Feng Y; Yan Z; Jiang X; Bukhari I; Iqbal F; Cooke HJ; Shi Q
    Cell Cycle; 2014; 13(22):3519-28. PubMed ID: 25483088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SATB2 and CDX2 are prognostic biomarkers in DNA mismatch repair protein deficient colon cancer.
    Ma C; Olevian D; Miller C; Herbst C; Jayachandran P; Kozak MM; Chang DT; Pai RK
    Mod Pathol; 2019 Jul; 32(8):1217-1231. PubMed ID: 30962505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The VTI1A-TCF4 colon cancer fusion protein is a dominant negative regulator of Wnt signaling and is transcriptionally regulated by intestinal homeodomain factor CDX2.
    Davidsen J; Larsen S; Coskun M; Gögenur I; Dahlgaard K; Bennett EP; Troelsen JT
    PLoS One; 2018; 13(7):e0200215. PubMed ID: 29975781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-derived exosomes orchestrate the microRNA-128-3p/ELF4/CDX2 axis to facilitate the growth and metastasis of gastric cancer via delivery of LINC01091.
    Wang Q; Zhang C; Cao S; Zhao H; Jiang R; Li Y
    Cell Biol Toxicol; 2023 Apr; 39(2):519-536. PubMed ID: 35674868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RAP80 and RNF8, key players in the recruitment of repair proteins to DNA damage sites.
    Yan J; Jetten AM
    Cancer Lett; 2008 Nov; 271(2):179-90. PubMed ID: 18550271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bile acids increase levels of microRNAs 221 and 222, leading to degradation of CDX2 during esophageal carcinogenesis.
    Matsuzaki J; Suzuki H; Tsugawa H; Watanabe M; Hossain S; Arai E; Saito Y; Sekine S; Akaike T; Kanai Y; Mukaisho K; Auwerx J; Hibi T
    Gastroenterology; 2013 Dec; 145(6):1300-11. PubMed ID: 23933602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CDX2 inhibits the proliferation and tumor formation of colon cancer cells by suppressing Wnt/β-catenin signaling via transactivation of GSK-3β and Axin2 expression.
    Yu J; Liu D; Sun X; Yang K; Yao J; Cheng C; Wang C; Zheng J
    Cell Death Dis; 2019 Jan; 10(1):26. PubMed ID: 30631044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ATDC (Ataxia Telangiectasia Group D Complementing) Promotes Radioresistance through an Interaction with the RNF8 Ubiquitin Ligase.
    Yang H; Palmbos PL; Wang L; Kim EH; Ney GM; Liu C; Prasad J; Misek DE; Yu X; Ljungman M; Simeone DM
    J Biol Chem; 2015 Nov; 290(45):27146-27157. PubMed ID: 26381412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDX2 inhibits pancreatic adenocarcinoma cell proliferation via promoting tumor suppressor miR-615-5p.
    Jiang Y; Zhang Y; Li F; Du X; Zhang J
    Tumour Biol; 2016 Jan; 37(1):1041-9. PubMed ID: 26269116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A microRNA expression signature as a predictor of survival for colon adenocarcinoma.
    Xu M; Kuang Y; Wang M; Han X; Yang Q
    Neoplasma; 2017; 64(1):56-64. PubMed ID: 27881005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential expression of miR-182 and miR-503 cooperatively targets FBXW7, contributing to the malignant transformation of colon adenoma to adenocarcinoma.
    Li L; Sarver AL; Khatri R; Hajeri PB; Kamenev I; French AJ; Thibodeau SN; Steer CJ; Subramanian S
    J Pathol; 2014 Dec; 234(4):488-501. PubMed ID: 25269767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-18a impairs DNA damage response through downregulation of ataxia telangiectasia mutated (ATM) kinase.
    Song L; Lin C; Wu Z; Gong H; Zeng Y; Wu J; Li M; Li J
    PLoS One; 2011; 6(9):e25454. PubMed ID: 21980462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of colorectal cancers with defective DNA damage repair by immunohistochemical profiling of mismatch repair proteins, CDX2 and BRCA1.
    Rajarajan S; C E A; Jose B; Correa M; Sengupta S; Prabhu JS
    Mol Clin Oncol; 2020 Nov; 13(5):57. PubMed ID: 32953111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ubiquitin Ligase, Fbw7, Targets CDX2 for Degradation via Two Phosphodegron Motifs in a GSK3β-Dependent Manner.
    Kumar Y; Shukla N; Thacker G; Kapoor I; Lochab S; Bhatt ML; Chattopadhyay N; Sanyal S; Trivedi AK
    Mol Cancer Res; 2016 Nov; 14(11):1097-1109. PubMed ID: 27470268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct mechanisms for opposite functions of homeoproteins Cdx2 and HoxB7 in double-strand break DNA repair in colon cancer cells.
    Soret C; Martin E; Duluc I; Dantzer F; Vanier M; Gross I; Freund JN; Domon-Dell C
    Cancer Lett; 2016 May; 374(2):208-15. PubMed ID: 26902420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-Level Control of the ATM/ATR-CHK1 Axis by the Transcription Factor E4F1 in Triple-Negative Breast Cancer.
    Batnini K; Houles T; Kirsh O; Du Manoir S; Zaroual M; Delpech H; Fallet C; Lacroix M; Le Cam L; Theillet C; Sardet C; Rodier G
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012478
    [No Abstract]   [Full Text] [Related]  

  • 19. CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer.
    Dalerba P; Sahoo D; Paik S; Guo X; Yothers G; Song N; Wilcox-Fogel N; Forgó E; Rajendran PS; Miranda SP; Hisamori S; Hutchison J; Kalisky T; Qian D; Wolmark N; Fisher GA; van de Rijn M; Clarke MF
    N Engl J Med; 2016 Jan; 374(3):211-22. PubMed ID: 26789870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNF8-dependent and RNF8-independent regulation of 53BP1 in response to DNA damage.
    Sakasai R; Tibbetts R
    J Biol Chem; 2008 May; 283(20):13549-55. PubMed ID: 18337245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.